Month: December 2021

Our article earned a top 10 ranking this year… …

Our article earned a top 10 ranking this year… https://t.co/3eBjWfXmEv Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Recently published, “Genes and Gene Therapy in Inherited Ret…

RT @ThomasCiullaMD: Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye #ophthalmology #retina #gene #genether… Source by Thomas Ciulla, MD, MBA Return to main website.

Honored to be recognized as a global expert in #maculardegeneration , a leading …


Honored to be recognized as a global expert in #maculardegeneration , a leading cause of irreversible vision loss: https://t.co/xLn1Vsjj5a
This recognition is based on scientific publications over the last 10 years, an objective process…
#AMD #retina #ASRS #clinicalresearch https://t.co/l9bnt4FRuj


Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Long-Term Outcomes of Anti-VEGF Therapy. Treatment burden is a …

Just published: Long-Term Outcomes of Anti-VEGF Therapy. Treatment burden is a barrier to real world #outcomes in #AMD, #diabetic & vein occlusion macular edema. Longer acting and more effective treatments are needed… #eye #retina @RetinaToday https://t.co/GuqOGPpmFM Source by Thomas Ciulla, MD, MBA Return to main 

RT @OTEurope: XIPERE, the first therapy utilising the suprachoroidal space, demo…

RT @OTEurope: XIPERE, the first therapy utilising the suprachoroidal space, demonstrates rapid efficacy, durable benefit and favourable saf… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ModernRetina: The first retinal gene therapy, voretigene neparvovec-rzyl (Lu…


RT @ModernRetina: The first retinal gene therapy, voretigene neparvovec-rzyl (Luxturna, Spark Ther­apeutics), was approved by the FDA in 20…


Source by Thomas Ciulla, MD, MBA

Return to main website.

Pleased to co-edit the 2nd of 2 #genetherapy issues of International Ophthalmolo…

Pleased to co-edit the 2nd of 2 #genetherapy issues of International Ophthalmology Clinics: “DNA- and RNA-based Gene Therapies in Ophthalmology: Inherited and Noninherited Retinal Disorders” #eye #ophthalmology #retina #IRD #gene https://t.co/4N9toRLDTO Source by Thomas Ciulla, MD, MBA Return to main website.

Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye …

Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye #ophthalmology #retina #gene #genetherapy #Luxturna #IRD #clinicalresearch #clinicaltrials #drugdevelopment #biotech https://t.co/u17zTf9Oox Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Looking forward to presenting on #suprachoroidal delivery at…


RT @ThomasCiullaMD: Looking forward to presenting on #suprachoroidal delivery at the Ophthalmology Innovation Source Drug Delivery Innovati…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @BauschSurgical: B+L and Clearside Biomedical announce the FDA approval of XI…

RT @BauschSurgical: B+L and Clearside Biomedical announce the FDA approval of XIPERE™ which utilizes the suprachoroidal space to treat pati… Source by Thomas Ciulla, MD, MBA Return to main website.